Anbio Biotechnology (NNNN) Interest & Investment Income (2025)

Anbio Biotechnology (NNNN) recorded quarterly Interest & Investment Income of $140237.0 in Q2 2025.

Anbio Biotechnology (NNNN) Interest & Investment Income (2025) Analysis & Trends

Anbio Biotechnology's Interest & Investment Income history runs 1 years deep, the most recent figure standing at $140237.0 for Q2 2025.

  • In Q2 2025, Interest & Investment Income changed N/A year-over-year to $140237.0; the TTM figure through Jun 2025 stood at $140237.0 (changed N/A YoY), while the FY2025 annual figure was $142023.0, down 57.92% from the prior year.
  • Interest & Investment Income was $140237.0 for Q2 2025 at Anbio Biotechnology.
  • In the past five years, Interest & Investment Income ranged from a high of $140237.0 in Q2 2025 to a low of $140237.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 9.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -136.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 12.29 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 5.10 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -62.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 3.91 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -66.00 Mn
10 Anbio Biotechnology 720.59 Mn 708.69 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 140,237.00